VIEMED HEALTHCARE, INC. Diluted Shares Outstanding (Weighted Average)
VIEMED HEALTHCARE, INC. (VMD) reported Diluted Shares Outstanding (Weighted Average) of 41.13 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-03
- VIEMED HEALTHCARE, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 41.13M shares, a 0.10% increase year-over-year.
- VIEMED HEALTHCARE, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 40.49M shares, a 2.73% decline year-over-year.
- VIEMED HEALTHCARE, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 40.04M shares, a 2.62% decline year-over-year.
- VIEMED HEALTHCARE, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 40.50M shares, a 0.70% decline year-over-year.
- VIEMED HEALTHCARE, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 40.82M shares, a 0.05% increase from fiscal 2024.
- VIEMED HEALTHCARE, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 40.81M shares, a 1.06% increase from fiscal 2023.
- VIEMED HEALTHCARE, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 40.38M shares, a 1.44% increase from fiscal 2022.
- VIEMED HEALTHCARE, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 39.81M shares, a 2.15% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 41.13M shares 10-Q · filed 2026-08-03 | 40.85M shares 10-Q · filed 2026-08-03 | 40.55M shares derived: average of 3 quarters · filed 2026-08-03 | 40.54M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | 40.49M shares 10-Q · filed 2026-05-05 | 40.26M shares derived: average of 2 quarters · filed 2026-05-05 | 40.34M shares derived: average of 3 quarters · filed 2026-05-05 | 40.53M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | 40.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 40.27M shares derived: average of 2 quarters · filed 2026-03-04 | 40.54M shares derived: average of 3 quarters · filed 2026-08-03 | 40.82M shares 10-K · filed 2026-03-04 |
| 2025-09-30 | 40.50M shares 10-Q · filed 2025-11-05 | 40.79M shares derived: average of 2 quarters · filed 2026-08-03 | 41.09M shares 10-Q · filed 2025-11-05 | 41.08M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | 41.08M shares 10-Q · filed 2026-08-03 | 41.39M shares 10-Q · filed 2026-08-03 | 41.28M shares derived: average of 3 quarters · filed 2026-08-03 | 41.15M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | 41.63M shares 10-Q · filed 2026-05-05 | 41.37M shares derived: average of 2 quarters · filed 2026-05-05 | 41.17M shares derived: average of 3 quarters · filed 2026-05-05 | 41.02M shares derived: average of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | 41.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 40.95M shares derived: average of 2 quarters · filed 2026-03-04 | 40.82M shares derived: average of 3 quarters · filed 2026-03-04 | 40.81M shares 10-K · filed 2026-03-04 |
| 2024-09-30 | 40.78M shares 10-Q · filed 2025-11-05 | 40.67M shares derived: average of 2 quarters · filed 2025-11-05 | 40.70M shares 10-Q · filed 2025-11-05 | 40.56M shares derived: average of 4 quarters · filed 2026-03-04 |
| 2024-06-30 | 40.55M shares 10-Q · filed 2025-08-06 | 40.31M shares 10-Q · filed 2025-08-06 | 40.49M shares derived: average of 3 quarters · filed 2026-03-04 | 40.47M shares derived: average of 4 quarters · filed 2026-03-04 |
| 2024-03-31 | 40.58M shares 10-Q · filed 2025-05-07 | 40.46M shares derived: average of 2 quarters · filed 2026-03-04 | 40.45M shares derived: average of 3 quarters · filed 2026-03-04 | 40.50M shares derived: average of 4 quarters · filed 2026-03-04 |
| 2023-12-31 | 40.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 40.38M shares derived: average of 2 quarters · filed 2026-03-04 | 40.48M shares derived: average of 3 quarters · filed 2026-03-04 | 40.38M shares 10-K · filed 2026-03-04 |
| 2023-09-30 | 40.42M shares 10-Q · filed 2024-11-06 | 40.55M shares derived: average of 2 quarters · filed 2024-11-06 | 40.39M shares 10-Q · filed 2024-11-06 | 40.20M shares derived: average of 4 quarters · filed 2025-03-10 |
| 2023-06-30 | 40.68M shares 10-Q · filed 2024-08-07 | 40.38M shares 10-Q · filed 2024-08-07 | 40.12M shares derived: average of 3 quarters · filed 2025-03-10 | 39.99M shares derived: average of 4 quarters · filed 2025-03-10 |
| 2023-03-31 | 40.02M shares 10-Q · filed 2024-05-06 | 39.84M shares derived: average of 2 quarters · filed 2025-03-10 | 39.76M shares derived: average of 3 quarters · filed 2025-03-10 | 39.76M shares derived: average of 4 quarters · filed 2025-03-10 |
| 2022-12-31 | 39.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | 39.63M shares derived: average of 2 quarters · filed 2025-03-10 | 39.67M shares derived: average of 3 quarters · filed 2025-03-10 | 39.81M shares 10-K · filed 2025-03-10 |
| 2022-09-30 | 39.58M shares 10-Q · filed 2023-11-01 | 39.67M shares derived: average of 2 quarters · filed 2023-11-01 | 39.85M shares 10-Q · filed 2023-11-01 | 40.07M shares derived: average of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | 39.75M shares 10-Q · filed 2023-08-09 | 40.06M shares 10-Q · filed 2023-08-09 | 40.23M shares derived: average of 3 quarters · filed 2023-08-09 | 40.34M shares derived: average of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | 40.36M shares 10-Q · filed 2023-05-08 | 40.47M shares derived: average of 2 quarters · filed 2023-05-08 | 40.53M shares derived: average of 3 quarters · filed 2023-05-08 | 40.66M shares derived: average of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | 40.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | 40.62M shares derived: average of 2 quarters · filed 2023-03-02 | 40.75M shares derived: average of 3 quarters · filed 2023-03-02 | 40.68M shares 10-K · filed 2023-03-02 |
| 2021-09-30 | 40.66M shares 10-Q · filed 2022-11-01 | 40.84M shares derived: average of 2 quarters · filed 2022-11-01 | 40.72M shares 10-Q · filed 2022-11-01 | 40.85M shares derived: average of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | 41.03M shares 10-Q · filed 2022-08-02 | 40.85M shares 10-Q · filed 2022-08-02 | 40.91M shares derived: average of 3 quarters · filed 2022-08-02 | 40.97M shares derived: average of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | 40.66M shares 10-Q · filed 2022-05-03 | 40.85M shares derived: average of 2 quarters · filed 2022-05-03 | 40.95M shares derived: average of 3 quarters · filed 2022-05-03 | 40.92M shares derived: average of 4 quarters · filed 2022-05-03 |
| 2020-12-31 | 41.04M shares 10-K · filed 2021-03-03 | 41.10M shares derived: average of 2 quarters · filed 2021-11-02 | 41.00M shares derived: average of 3 quarters · filed 2021-11-02 | 40.53M shares 10-K · filed 2022-03-07 |
| 2020-09-30 | 41.16M shares 10-Q · filed 2021-11-02 | 40.98M shares derived: average of 2 quarters · filed 2021-11-02 | 40.38M shares 10-Q · filed 2021-11-02 | 40.45M shares derived: average of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | 40.81M shares 10-Q · filed 2021-08-03 | 40.10M shares 10-Q · filed 2021-08-03 | 40.21M shares derived: average of 3 quarters · filed 2021-08-03 | 40.17M shares derived: average of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | 39.68M shares 10-Q · filed 2021-05-03 | 39.91M shares derived: average of 2 quarters · filed 2021-05-03 | 39.96M shares derived: average of 3 quarters · filed 2021-05-03 | 39.96M shares derived: average of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | 40.15M shares 10-K · filed 2021-03-03 | 40.10M shares derived: average of 2 quarters · filed 2021-03-03 | 40.06M shares derived: average of 3 quarters · filed 2021-03-03 | 39.75M shares 10-K · filed 2021-03-03 |
| 2019-09-30 | 40.05M shares 10-K · filed 2021-03-03 | 40.01M shares derived: average of 2 quarters · filed 2021-03-03 | 39.77M shares 10-Q · filed 2020-11-04 | 39.90M shares derived: average of 4 quarters · filed 2021-03-03 |
| 2019-06-30 | 39.98M shares 10-K · filed 2021-03-03 | 40.17M shares 10-Q · filed 2020-08-04 | 39.85M shares derived: average of 3 quarters · filed 2021-03-03 | 39.88M shares derived: average of 4 quarters · filed 2021-03-03 |
| 2019-03-31 | 39.45M shares 10-K · filed 2021-03-03 | 39.79M shares derived: average of 2 quarters · filed 2021-03-03 | 39.84M shares derived: average of 3 quarters · filed 2021-03-03 | 39.71M shares derived: average of 4 quarters · filed 2021-03-03 |
| 2018-12-31 | 40.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | 40.04M shares derived: average of 2 quarters · filed 2020-03-04 | 39.80M shares derived: average of 3 quarters · filed 2020-03-04 | 39.68M shares 10-K · filed 2020-03-04 |
| 2018-09-30 | 39.95M shares 10-Q · filed 2019-11-05 | 39.64M shares derived: average of 2 quarters · filed 2019-11-05 | 39.53M shares 10-Q · filed 2019-11-05 | |
| 2018-06-30 | 39.34M shares 10-Q · filed 2019-08-09 | 39.10M shares 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |